National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 37887 [2017-17040]

Download as PDF Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices harmonization of new, revised, and alternative toxicological test methods. Additional information about SACATM, including the charter, roster, and records of past meetings, can be found at https://ntp.niehs.nih.gov/go/167. Dated: August 1, 2017. John R. Bucher, Associate Director, National Toxicology Program. Dated: August 8, 2017. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HOMELAND SECURITY [FR Doc. 2017–17040 Filed 8–11–17; 8:45 am] [Docket No. USCG–2017–0194] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2017–17036 Filed 8–11–17; 8:45 am] Substance Abuse and Mental Health Services Administration BILLING CODE 4140–01–P 37887 Coast Guard Waterway Suitability Assessment for Operation of Liquefied Hazardous Gas Terminal; Port Arthur, TX Coast Guard, DHS. Notice and request for comments. AGENCY: ACTION: In accordance with Coast Guard regulations, Lynx Terminals LLC (Lynx Terminals) has submitted a Letter of Intent and Preliminary Waterway Suitability Assessment to the Coast Guard Captain of the Port, Port Arthur, TX (COTP) regarding the company’s plans to handle and transport Liquefied Hazardous Gas (LHG) at the Port of Port Arthur docks in Port Arthur, TX. The Coast Guard is notifying the public of this proposed increase in LHG marine traffic on the Sabine-Neches Waterway and is soliciting comments relevant to the Coast Guard’s preparation of a Letter of Recommendation (LOR) for issue to the federal, state or local agency with jurisdiction over the proposed facility. DATES: Comments and related material must be received on or before September 13, 2017. ADDRESSES: You may submit comments identified by docket number USCG– 2017–0194 using the Federal eRulemaking Portal at https:// www.regulations.gov. See the ‘‘Public Participation and Request for Comments’’ portion of the SUPPLEMENTARY INFORMATION section below for further instructions on submitting comments. FOR FURTHER INFORMATION CONTACT: If you have questions on this notice, call or email Commander Loan T. O’Brien, U.S. Coast Guard; telephone 409–723– 6564, email: Loan.T.O’Brien@uscg.mil. SUPPLEMENTARY INFORMATION: SUMMARY: Notice of Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting sradovich on DSK3GMQ082PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel NIAID Clinical Trial Planning Grant (R34), Implementation Cooperative Agreement (U01) and SBIR Phase II Implementation Cooperative Agreement (U44). Date: September 12, 2017. Time: 10:00 a.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Maryam Feili-Hariri, Ph.D., Scientific Review Officer Scientific Review Program Division of Extramural Activities, National Institutes of Health/ NIAID, 5601 Fishers Lane, Rockville, MD 20852, 240–669–5026, haririmf@ niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) VerDate Sep<11>2014 16:45 Aug 11, 2017 Jkt 241001 Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) National Advisory Council will meet on August 25, 2017, 10:00 a.m.– 11:00 a.m., in Rockville, MD. The meeting will include the review, discussion, and evaluation of grant applications reviewed by the Initial Review Group, and involve an examination of confidential financial and business information as well as personal information concerning the applicants. Therefore, this meeting will be closed to the public as determined by the Acting Deputy Assistant Secretary for Mental Health and Substance Use, in accordance with Title 5 U.S.C. 552b(c)(4) and (c)(6) and 5 U.S.C. App. 2, Section 10(d). Committee Name: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention National Advisory Council. Date/Time/Type: August 25, 2017, 10:00 a.m.–11:00 a.m. (Closed). Place: SAMHSA Building, 5600 Fishers Lane, Rockville, MD 20852. Contact: Matthew J. Aumen, Designated Federal Officer, SAMHSA/ CSAP National Advisory Council, 5600 Fishers Lane, Rockville, MD 20852, Email: Matthew.Aumen@ samhsa.hhs.gov. Carlos R. Castillo, Committee Management Officer, SAMHSA. [FR Doc. 2017–17074 Filed 8–11–17; 8:45 am] BILLING CODE 4162–20–P PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 Public Participation and Request for Comments We encourage you to submit comments and related material in response to this notice through the Federal eRulemaking Portal at https:// www.regulations.gov. We will consider all submissions and may adjust our final action based on your comments. If you submit a comment, please include the docket number for this notice, indicate the specific section of this document to which each comment applies, and provide a reason for each suggestion or recommendation. We encourage you to submit comments through the Federal E:\FR\FM\14AUN1.SGM 14AUN1

Agencies

[Federal Register Volume 82, Number 155 (Monday, August 14, 2017)]
[Notices]
[Page 37887]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17040]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel NIAID Clinical Trial Planning Grant 
(R34), Implementation Cooperative Agreement (U01) and SBIR Phase II 
Implementation Cooperative Agreement (U44).
    Date: September 12, 2017.
    Time: 10:00 a.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Maryam Feili-Hariri, Ph.D., Scientific Review 
Officer Scientific Review Program Division of Extramural Activities, 
National Institutes of Health/NIAID, 5601 Fishers Lane, Rockville, 
MD 20852, 240-669-5026, haririmf@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 8, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-17040 Filed 8-11-17; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.